Group 3 comprised two parenteral drug abusers, both of whom had had two attacks of acute hepatitis.
Serum specimens were obtained from all patients at weekly intervals or more often if indicated and stored at -20 C. Tests of liver function included measurement of serum bilirubin and aminoaspartate transferase levels. In each patient the illness was measured from the onset of symptoms. At least two serum specimens from each patient were examined under code for HBsAg and HBsAb by solid phase radioimmunoassay' and radioimmunoprecipitation (RIP)9 respectively, and at least two specimens were examined for HAAb by immune adherence haemagglutination."' Serological tests to detect infection with cytomegalovirus, herpes simplex virus, Epstein-Barr virus, Mycoplasma pnieinmoniae, Coxiella burnzettii, Toxoplasmiza gonidii, Leptospira interroganls, Treponemena pallidumn, and Brucella abortuis were performed by standard methods. Antibody responise-The figure shows the HAAb titre related to time from the onset of dark urine in the 22 patients in whom a diagnosis of hepatitis A was confirmed by seroconversion or a rise in antibody titre. HAAb was rarely detected within three weeks of the onset of symptoms. Of the 21 sera obtained during this period only four contained antibody and none of these were taken in the first week. Four out of five sera collected during the fourth week of illness contained HAAb, and all sera obtained after this was positive. The general pattern of response indicated that peak titres may not be reached for eight or nine weeks after the onset of symptoms. 
Discussion
In this study hepatitis A virus was implicated as the aetiological agent in six family outbreaks of non-B hepatitis. Of the 16 patients affected, 14 developed rising titres of HAAb. In the other two hepatitis A could be confidently diagnosed on epidemiological grounds as their contacts showed serological evidence of infection. Failure to confirm the diagnosis in these two patients was probably due to the absence of adequate specimens. One (case 6) was not seen until 58 days after the onset of t * * 0
. illness, at which time she had a titre of HAAb consistent with recent infection. Another patient (case 8), in whom the level of HAAb did not rise significantly between days 13 and 29 of illness, had received an injection of human normal immunoglobulin 10 days before the onset of symptoms, which may have caused a modified antibody response. Two studies of sporadic non-B hepatitis have been reported recently. In the first a highly selected group of patients was tested, and infection with hepatitis A virus was confirmed in only two out of 73 patients. 4 The second study, which was carried out prospectively in Los Angeles, found only 48°, of sporadic non-B hepatitis to be type A (J L Dienstag et al, personal communication) and suggested that the remaining cases may have been due to other, as yet unidentified, viruses. In Melbourne infection with hepatitis A virus was confirmed in seven of the eight patients with sporadic disease, but the small number of patients studied makes it impossible to draw firm conclusions about the prevalence of non-A non-B hepatitis. The patient in whom hepatitis A was not diagnosed had a rising titre of complement fixation antibody to cytomegalovirus.
Until 1971 hepatitis B was uncommon in Melbourne, "1 and second attacks of hepatitis were almost unknown.12 In the last two years, however, several patients (usually intravenous drug users) have been admitted with second and even third attacks. Each of the two such patients studied was found to have had one attack of hepatitis B, and one had had an attack of hepatitis A. The remaining episode of hepatitis was not diagnosed. HAAb was not detected in acute and convalescent serum samples and no evidence was obtained of infection with other viral, bacterial, or rickettsial agents known to produce acute liver damage. Possibly this illness may have been due to a hepatitis virus other than A or B.
The antibody response to hepatitis A virus, detected by immune adherence haemagglutination, was similar to that described in a group of patients who developed hepatitis after eating contaminated shellfish.7 HAAb was not detected in sera collected during the first week after the onset of symptoms and was detected in only three of the 12 sera collected during the second week. In most patients antibody was first detected in the third or fourth week after the onset of symptoms, then rose in titre, peaking in the eighth or ninth week. No substantial data on the duration of antibody were obtained, but in two patients from whom sera were obtained at 210 days and 217 days no fall in titre had occurred.
Our results confirm that the detection of rising titres of HAAb by immune adherence haemagglutination is a reliable index of infection with the hepatitis A virus and that the presence of antibody in high titre during the first two weeks of illness or its absence in sera collected six weeks or more after the onset of symptoms makes a diagnosis of hepatitis A unlikely.
Introduction
The acute-phase reactants are a class of serum proteins, mainly glycoproteins, whose concentration in the blood increases after various stimuli such as trauma or inflammation.' The magnitude of the acute-phase protein response is roughly proportional to the severity of the stimulus.2 3 Serial measurements of these proteins can therefore be used, like the erythrocyte sedimenta-
